Zenith Drugs

Zenith Drugs

63.00
-2.25
(-3.45%)
Market Cap
108.00 Cr
EPS
5.63
PE Ratio
10.28
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
154.40
52 Week Low
47.15
PB Ratio
1.74
Debt to Equity
0.63
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
positive
Zenith Drugs Secures Two Tenders Worth 83.3 Million RupeesMar 17, 2025
Zenith Drugs has been awarded two tenders with a combined value of 83.3 million rupees. The first tender is worth 68.3 million rupees, while the second is valued at 15 million rupees. The company's current market capitalization stands at 943 million rupees.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,586.70
#1 3,80,702.50
33.18
#1 54,729.00
9.71
#1 10,980
-19.84
51.86
5,689.50
1,51,038.30
65.50
9,712.00
18.67
2,191
26.74
36.39
1,499.40
1,21,107.70
22.45
28,409.50
7.12
5,291
9.88
38.89
3,561.00
1,20,520.40
59.72
11,539.40
6.99
1,911
19.91
42.61
1,253.10
1,04,580.10
#1 18.40
33,741.20
16.73
5,725
1.26
46.51
2,482.90
1,02,476.40
54.18
12,744.20
#1 20.90
2,007
-18.14
44.66
975.00
98,107.80
21.07
23,511.00
18.55
4,615
2.60
50.50
1,919.80
87,676.40
23.72
22,909.50
13.74
3,306
#1 51.64
46.16
5,433.00
64,959.70
28.53
13,458.30
3.70
2,216
21.39
61.31
1,090.00
63,307.40
18.84
32,345.60
9.43
3,484
-10.24
53.78
Forecast
Actual
Growth Rate
Revenue Growth
15.46 %
Net Income Growth
95.92 %
Cash Flow Change
-172.75 %
ROE
-43.75 %
ROCE
-32.19 %
EBITDA Margin (Avg.)
60.07 %

Yearly Financial Results

Annual Financials
2022
2023
2024
TTM
Revenue
93
116
134
0
Expenses
85
106
115
0
EBITDA
8
10
19
0
Operating Profit %
7 %
8 %
13 %
0 %
Depreciation
1
1
1
0
Interest
2
2
3
0
Profit Before Tax
4
7
13
0
Tax
1
2
4
0
Net Profit
3
5
10
0
EPS in ₹
78.22
122.02
5.63
0.00

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
69
98
135
Fixed Assets
11
12
11
Current Assets
54
84
113
Capital Work in Progress
3
0
4
Investments
0
0
0
Other Assets
55
86
120
Total Liabilities
69
98
135
Current Liabilities
47
72
64
Non Current Liabilities
10
9
9
Total Equity
12
18
62
Reserve & Surplus
12
17
45
Share Capital
0
0
17

Cash Flow

Cash Flow
2022
2023
2024
Net Cash Flow
1
-0
9
Investing Activities
-5
-0
26
Operating Activities
5
-5
-13
Financing Activities
1
5
-5

Share Holding

% Holding
Sept 2023
Feb 2024
Mar 2024
Sept 2024
Mar 2025
Promoter
100.00 %
100.00 %
69.98 %
69.98 %
69.98 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
15.20 %
25.57 %
25.56 %
Others
0.00 %
0.00 %
14.83 %
4.45 %
4.46 %
No of Share Holders
7
7
1,117
1,355
1,544

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.5 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.7 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
18 Sept 2024 DIVIDEND Dividend
₹ 0.50 /share
17 Sept 2024 65.25 135.65
25 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Sept 2024 107.60 126.05
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 108.95 102.35
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 78.45 79.05

Technical Indicators

RSI(14)
Neutral
38.22
ATR(14)
Volatile
2.47
STOCH(9,6)
Neutral
30.69
STOCH RSI(14)
Neutral
45.67
MACD(12,26)
Bearish
-0.40
ADX(14)
Weak Trend
20.12
UO(9)
Bearish
45.37
ROC(12)
Downtrend And Accelerating
-8.56
WillR(14)
Oversold
-95.24